Long-term follow-up in patients with gastric antral vascular ectasia (GAVE) after treatment with endoscopic band ligation (EBL)
submitted 10 March 2019
accepted after revision 12 June 2019
25 November 2019 (online)
Background and study aims Gastric antral vascular ectasia (GAVE) is a capillary-type vascular malformation of the gastric antrum, usually diagnosed endoscopically in patients presenting with iron deficiency anemia or gastrointestinal bleeding. While there is established evidence for treatment with thermal modalities, such as argon plasma coagulation (APC) therapy, more recent studies have shown endoscopic band ligation (EBL) to be safe and effective in achieving remission. Our study aimed to evaluate long-term outcomes of patients with GAVE who underwent EBL at our institution.
Patients and methods We retrospectively reviewed data from 33 patients with GAVE who underwent esophagogastroduodenoscopy and EBL between September 2012 and July 2017 within our institution, looking primarily at clinical response, recurrence, and blood transfusion requirements.
Results Clinical response was achieved in 27 patients (81.8%). Among responders, recurrence-free survival decreased with time from 88 % at 1 year to 44 % at 2 years. Thirteen patients (48.1 %) had recurrence of GAVE at a mean time of 18.2 months (range 4.7 – 51.8). The only predictor of recurrence was greater number of pre-procedure blood transfusions.
Conclusion This is the first study to evaluate long-term response and recurrence in patients with GAVE after treatment with EBL and predictors of clinical response after initial endoscopic therapy have been identified. While we were able to demonstrate excellent remission achievement rates in our GAVE patients who had undergone EBL, close clinical follow-up is clearly required as almost 50 % will have recurrence at around 18 months.
- 1 Fuccio L, Mussetto A, Laterza L. et al. Diagnosis and management of gastric antral vascular ectasia. Gut 1995; 37: 488-492
- 2 Ito M, Uchida Y, Kamano S. et al. Clinical comparison between two subsets of gastric antral vascular ectasia. Gastrointest Endosc 2001; 53: 764-770
- 3 Suit PF, Petras RE, Bauer TW. et al. Gastric antral vascular ectasia. A histologic and morphometric study of watermelon stomach. Am J Pathol 1987; 11: 750-757
- 4 Zepeda-Gómez S. Endoscopic treatment for gastric antral vascular ectasia: Current options. GE Port J Gastroenterol 2017; 24: 176-182
- 5 Boltin D, Gingold-Belfer R, Lichtenstein L. et al. Long-term treatment outcome of patients with gastric antral vascular ectasia treated with argon plasma coagulation. Eur J Gastroenterol Hepatol 2014; 26: 588-593
- 6 Baudet JS, Diaz-Bethencourt D, Soler M. et al. Long-term follow-up of patients with gastric antral vascular ectasia treated with argon plasma coagulation. Med Clin (Barc) 2009; 11: 217-220
- 7 Nakamura S, Mitsunaga A, Konishi H. et al. Long-term follow up of gastric antral vascular ectasia treated by argon plasma coagulation. Dig Endosc 2006; 18: 128-133
- 8 Sinha SK, Udawat HP, Varma S. et al. Watermelon stomach treated with endoscopic band ligation. Gastrointest Endosc 2013; 5: 135-137
- 9 Zepeda-Gómez S, Sultanian R, Teshima C. et al. Gastric antral vascular ectasia: a prospective study of treatment with endoscopic band ligation. Endoscopy 2015; 47: 538-540
- 10 Wells CD, Harrison ME, Gurudu SR. et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc 2008; 68: 231-236
- 11 Elhendaway M, Mosaad S, Alkhalawany W. et al. Randomized controlled study of endoscopic band ligation and argon plasma coagulation in the treatment of gastric antral and fundal vascular ectasia. United European Gastroenterol J 2016; 4: 423-428
- 12 Polski JM, Brunt EM, Saeed ZA. Chronology of histological changes after band ligation of esophageal varices in humans. Endoscopy 2001; 33: 443-447